hydroxyindoleacetic acid has been researched along with Cognitive Dysfunction in 5 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
Cognitive Dysfunction: Diminished or impaired mental and/or intellectual function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cognitive dysfunction is a severe issue of Alzheimer's disease." | 5.91 | Propofol protects rats against intra-cerebroventricular streptozotocin-induced cognitive dysfunction and neuronal damage. ( Dou, X; Sun, L; Yang, W, 2023) |
| "Cognitive dysfunction is a severe issue of Alzheimer's disease." | 1.91 | Propofol protects rats against intra-cerebroventricular streptozotocin-induced cognitive dysfunction and neuronal damage. ( Dou, X; Sun, L; Yang, W, 2023) |
| "Lewy body disorders, including Parkinson's disease (PD), Parkinson's disease dementia (PDD) and dementia with Lewy bodies (DLB), are characterized by profound central and peripheral monoaminergic dysfunction." | 1.48 | Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease. ( Aerts, T; De Deyn, PP; Fransen, E; Gerritsen, MJ; Spikman, JM; Van Dam, D; van der Zee, S; van Laar, T; Vermeiren, Y, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, L | 1 |
| Dou, X | 1 |
| Yang, W | 1 |
| Zubov, AS | 1 |
| Ivleva, IS | 1 |
| Pestereva, NS | 1 |
| Tiutiunnik, TV | 1 |
| Traktirov, DS | 1 |
| Karpenko, MN | 1 |
| Hou, Z | 1 |
| Yang, X | 1 |
| Jiang, L | 1 |
| Song, L | 1 |
| Li, Y | 1 |
| Li, D | 1 |
| Che, Y | 1 |
| Zhang, X | 1 |
| Sun, Z | 1 |
| Shang, H | 1 |
| Chen, J | 1 |
| van der Zee, S | 1 |
| Vermeiren, Y | 1 |
| Fransen, E | 1 |
| Van Dam, D | 1 |
| Aerts, T | 1 |
| Gerritsen, MJ | 1 |
| Spikman, JM | 1 |
| van Laar, T | 1 |
| De Deyn, PP | 1 |
| Tajeddinn, W | 1 |
| Fereshtehnejad, SM | 1 |
| Seed Ahmed, M | 1 |
| Yoshitake, T | 1 |
| Kehr, J | 1 |
| Shahnaz, T | 1 |
| Milovanovic, M | 1 |
| Behbahani, H | 1 |
| Höglund, K | 1 |
| Winblad, B | 1 |
| Cedazo-Minguez, A | 1 |
| Jelic, V | 1 |
| Järemo, P | 1 |
| Aarsland, D | 1 |
5 other studies available for hydroxyindoleacetic acid and Cognitive Dysfunction
| Article | Year |
|---|---|
Propofol protects rats against intra-cerebroventricular streptozotocin-induced cognitive dysfunction and neuronal damage.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholinesterase; Animals; Cognitive Dysfunction; Dopamine; Hipp | 2023 |
Glibenclamide alters serotonin and dopamine levels in the rat striatum and hippocampus, reducing cognitive impairment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cognitive Dysfunction; Corpus Striatum; Dopamine; Glyburide | 2022 |
Active components and molecular mechanisms of Sagacious Confucius' Pillow Elixir to treat cognitive impairment based on systems pharmacology.
Topics: Animals; Cognitive Dysfunction; Hydroxyindoleacetic Acid; Mice; Molecular Docking Simulation; Networ | 2023 |
Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease.
Topics: Aged; Biogenic Monoamines; Biomarkers; Cognition Disorders; Cognitive Dysfunction; Diagnosis, Differ | 2018 |
Association of Platelet Serotonin Levels in Alzheimer's Disease with Clinical and Cerebrospinal Fluid Markers.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Blood Platelets; Chromatography, High Pressure Liquid; Cog | 2016 |